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ABSTRACT
Purpose: To compare the effect of parenteral versus enteral nutritional support in severe acute pancreatitis, with respect to efficacy,
safety, morbidity, mortality and length of hospitalization. Methods: The study was comprised of 31 patients, divided into a parenteral
group (n=16) and an enteral group (n=15), who met severity criteria for abdominal tomography (Balthazar classes C, D, and E). The
patients were compared by demographics, disease etiology, antibiotic prophylaxis, use or not of somatostatin, nutritional support,
complications and disease progression. Results: There was no statistical difference in the average duration of nutritional support,
somatostatin, or antibiotics in the two groups. Imipenem was the drug of choice for prophylaxis of pancreatic infections in both
groups. More complications occurred in the parenteral group, although the difference was not statistically significant (p=0.10).
Infectious complications, such as catheter sepsis and infections of the pancreatic tissue, were significantly more frequent in the
parenteral group (p=0.006). There was no difference in average length of hospitalization in the two groups. There were three deaths in
the parenteral group and none in the enteral group. Conclusion: Enteral nutritional support is associated with fewer septic complications
compared to parenteral nutritional support.
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RESUMO
Objetivo: Comparar o efeito do suporte nutricional parenteral versus enteral, em pancreatite aguda grave, com relação à eficácia, à
segurança, à morbi-mortalidade e ao tempo de internação. Métodos: Foram estudados 31 pacientes distribuídos em grupo parenteral
(n=16), no período de 1995 a 1998 e grupo enteral (n=15), no período de 1999 a 2002, que preencheram os critérios de gravidade pela
tomografia de abdome (Balthazar C,D,E). Os pacientes foram comparados quanto aos dados demográficos, etiologia, antibioticoprofilaxia,
somatostatina, suporte nutricional, complicações e evolução. Resultados: A maioria dos pacientes era Balthazar E, principalmente no
grupo enteral, porém sem significado estatístico (p=0,21). Também não houve diferença estatística nos dois grupos em relação ao tempo
médio de uso de suporte nutricional, somatostatina e antibiótico. O imipenem foi a droga de escolha para profilaxia da infecção pancreática
nos dois grupos. Houve mais complicações gerais no grupo parenteral, sem significado estatístico (p=0,10). As complicações infecciosas
do tipo sépsis do cateter e infecção do tecido pancreático foram mais frequentes no grupo parenteral, com significância estatística
(p=0,06). Não houve diferença na média de internação nos dois grupos. Houve três óbitos no grupo parenteral e nenhum no enteral.
Conclusão: O suporte nutricional enteral está associado à menor taxa de complicações sépticas do que o parenteral.
Descritores: Apoio Nutricional. Nutrição Parenteral. Nutrição Enteral. Pancreatite.
1Research performed at the Intensive Care, Sao Domingos Hospital, Sao Luis-MA, Brazil.
Introduction
Severe acute pancreatitis is found in 20-30% of patients
with pancreatitis and is associated with increased risk of
complications, such as multiple organ failure, necrosis, abscess
and formation of pancreatic pseudocysts1. It represents a clinical
challenge in intensive care, requiring prolonged hospitalization
and a multidisciplinary approach, including hydro-electrolyte
resuscitation, antibiotic prophylaxis, hemodynamic, respiratory,
and renal support and artificial nutrition2.
This illness is associated with a systemic
immunoinf lammatory response  that  culminates  wi th
hypermetabolism and high rates of protein catabolism;
consequently, nutritional reserves are rapidly consumed and
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malnutrition may appear unless a higher nutritional intake is
provided2. Thus, early nutritional support plays a central role in
the management of these patients3.
Total parenteral nutritional support has long been the
standard source of exogenous nutrients for these patients, however
this is costly and associated with many disadvantages, including
dysfunction of the intestinal mucosal barrier, which, in turn,
promotes sepsis of intestinal origin3,4.
Circumventing the intestine as the route of nutrient
administration contributes to loss of the mucosal barrier’s
integrity, exacerbating the stress and systemic inflammatory
responses, aggravating the disease and potentially leading to the
development of multiple organ failure, sepsis, and nosocomial
infections5. Enteral nutrition, on the other hand, can maintain the
integrity and function of the intestinal mucosal barrier6.
The degree of pancreatic stimulation is determined by the
location in the gastrointestinal tract where food is administered7,
i.e., pancreatic rest can be achieved if food is administered in the
small intestine, distal to the angle of Treitz, which results in
minimal or negligible stimulation of pancreatic secretion8.
Randomized clinical studies comparing parenteral vs.
enteral nutrition in severe acute pancreatitis have demonstrated
clear advantages of enteral nutrition. McClave et al.9 observed that
enteral nutrition was equally safe and effective and significantly
cheaper than total parenteral nutrition, and was also associated with
faster resolution of toxicity and stress related to pancreatitis.
Kalfarentzos et al.6 demonstrated that enteral nutrition was
well tolerated and was associated with fewer adverse effects or
septic complications over the course of the illness, as well as with
lower mortality. The cost of enteral nutrition was one-third of the
cost of total parenteral nutrition.
Lower rates of sepsis, systemic inflammatory response
syndrome (SIRS), and organ failure, as well as shorter hospital
stays in the intensive care unit, have been reported in patients with
severe acute pancreatitis on enteral vs. total parenteral nutrition10.
The objective of this study was to compare parenteral vs.
enteral nutritional support in the management of patients with
severe acute pancreatitis, with regards to efficacy, security,
morbidity, mortality and hospitalization time.
Methods
All patients diagnosed with acute pancreatitis who were
admitted to the intensive care unit of the Hospital Sao Domingos
(Sao Luis-MA) between January 1995 and December 2002 were
studied. The diagnosis was confirmed by elevations in levels of
pancreatic enzymes (amylase and lipase), abdominal ultrasound
and contrast-enhanced abdominal computerized tomographic (CT)
imaging.
To stage the severity of pancreatic disease, the Balthazar
tomographic classification was used11. Patients classified as
Balthazar A and B and those who were transferred to other services
during the course of treatment were excluded from the study.
All patients underwent a rigorous clinical treatment
protocol consisting of adequate central venous fluid replacement,
hemodynamic monitoring via central venous pressure (CVP),
analgesia, H2-receptor blockers to prevent stress ulcers, a nasogastric
tube to maintain gastric suction, prophylaxis with imipenem for
pancreatic infection, inhibition of pancreatic secretions with
somatostatin, parenteral or enteral nutritional support, and
respiratory and renal support as needed.
Patients were evaluated for surgical treatment only when
the following complications occurred: septic necrosis, abscess,
infected pseudocyst and digestive fistulas. When indicated,
patients were evaluated for elective open or laparoscopic
cholecystectomy, after resolution of the pancreatic disease, to be
performed preferably in the same hospital.
From January 1995 to June 1999, all seriously ill patients
were fed via the parental route; all other patients received jejunal
enteral nutrition. In this way, patients were divided into two groups
according to the type of nutritional support administered.
Patients in Group A (parenteral nutrition) received a diet
administered parenterally via a continuous infusion through a
double-lumen polyurethane catheter placed in the superior vena
cava by infra-clavicular puncture of the subclavian vein and
post-procedural radiological control. This nutrition was composed
of a calorie source made up of 70% carbohydrates and 30% lipids,
as well as protein, supplied by a standard 10% amino acid solution,
thus establishing a nitrogen/calorie ratio of 1/128. Nutrition was
started early (in the first 24–48 hours after admission) and was
estimated at 25–30 kcal/kg/day.
Patients in Group B (enteral nutrition) received a
polymeric diet, administered by the enteral route, via continuous
infusion through a polyurethane tube placed in the first jejunal
loop and placed with the help of an endoscopist with radiographic
confirmation of placement after the procedure. Feeding was started
early (in the first 24–48 hours of admission) and was estimated at
25–30 kcal/kg/day.
All patients were evaluated according to a previously
established summary protocol that included data on etiology of
the pancreatic disease, prophylactic antibiotic chosen, use or not
of somatostatin, nutritional support, length of hospital stay,
complications, disease progression, reactivation of the disease and
daily nutritional cost.
The two groups were compared with respect to gender,
age, etiology, severity, use of prophylactic antibiotics, use of
somatostatin, general and infectious complications and disease
progression to discharge or death.
Qualitative variables were grouped into proportions, and
quantitative variables were expressed as means with standard
deviations. Differences between qualitative variables were analyzed
by the chi-squared and Fisher’s exactest test where appropriate,
while quantitative variables were evaluated using Student’s t-test.
The rate of rejection was defined as < 5%.
Results
From January 1995 to December 2002, 48 patients
diagnosed with acute pancreatitis were admitted to the intensive
care unit of Sao Domingos Hospital. Fifteen were excluded for not
meeting severity criteria according to the Balthazar tomographic
classification, and two were transferred to other services. Ultimately,
31 cases were included in this study, of whom 19 (61.2%) were
males and 12 (38.7%) were females. The average age was
45.0±18.0 years. Gallstones and alcoholism were the main causes
of pancreatic disease.
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Sixteen patients (51.6%) were treated with total parenteral
nutritional support (Group A), and the other 15 patients (48.4%)
with enteral nutritional support (Group B).
The prevalence of disease based on gender was similar in
the two groups (p=0.886), and the average age in each group was
47.5±21.6 and 44.0±14.5 years, respectively (p=0.604). Gallstones
and alcoholism were the principal causes of pancreatic disease,
with 12 (80.0%) cases of gallstone pancreatitis and 8 (50.0 %) cases
of alcohol-induced pancreatitis in Group A, versus 6 (37%) and 2
(16.4%), respectively, in group B (p=0.21).
According to the Balthazar criteria19, most patients were
considered very severe (7 cases (43.8%) in group A vs. 11 (71.6%)
in group B), with no significant difference between the groups
(p=0.21) (Table 1).
TABLE 1 - Distribution of patients with acute pancreatitis in groups A
and B, based on the Balthazar tomographic classification
 A B 
Balthazar N % N % 
C 6 37.5 2 14.2 
D 3 18.7 2 14.2 
E 7 43.8 11 71.6 
Total 16 100.0 15 100.0
Chi-squared p=0.21
There was no statistical difference in average use of
nutritional support, antibiotics or somatostatin between the
two groups studied (p=0.672; p=0.062; p=0.140, respectively)
(Table 2).
TABLE 2 - Distribution of patients with acute pancreatitis in groups A
and B, by duration of antibiotic therapy, use or not of somatostatin and
nutritional route
Group A B 
Time (days) Mean SD Mean SD 
Antibiotic* 15.75 4.67 15.15 1.77 
Somatostatin** 5.93 2.64 7.93 2.89 
Nutrition*** 13.94 7.68 17.87 6.66 
*Student’s t-test – p=0.672
** Student’s t-test - p=0.062
*** Student’s t-test - p=0.140
TABLE 3 - Distribution of patients with acute pancreatitis in groups A
and B by antibiotic used
Group A B 
Antibiotic N % N % 
Imipenem  11 68.8 11 73.3 
Ciprofloxacin  1   6.2 1   6.7 
Ciprofloxacin+ 
Metronidazole 
– – 1   6.7 
Not Used 4 25.0 2 13.3 
Total 16 100.0 15 100.0 
The majority of patients received only clinical treatment
(11 (68.7%) cases in Group A and 11 (73.3%) in group B). Of the 5
cases in group A that underwent surgical intervention, 3 (18.6%)
were performed on the pancreas. In group B, interventions were
performed only on the bile ducts (4 cases (26.6%)). However, there
was no significant difference between the two groups (p=0.226)
(Table 4).
TABLE 4 - Distribution of patients with acute pancreatitis in groups A
and B by surgical treatment
Group A B 
Surgery N % N % 
Laparoscopic 
cholecystectomy  
– – 3 20.0 
Laparoscopic 
cholecystectomy + 
endoscopic papillotomy 
– – 1   6.6 
Conventional open 
cholecystectomy 
1  6.2 – – 
Total pancreatectomy + 
pancreatic necrosectomy + 
retroperitoneal drainage 
1  6.2 – – 
Endoscopic papillotomy 1  6.2 – – 
Pancreatic necrosectomy+ 
retroperitoneal drainage 
2 12.6 – – 
No operation 11 68.8 11 73.4 
Total 16 100.0 15 100.0
(p=0.654), with imipenem being the primary option for 11 (91.7%,
Group A) and 11 (84.6%, Group B) patients (p=1.000) (Table 3).
Twelve (75%, Group A) and 13 (86.7%, Group B)
patients used prophylactic antibiotics for pancreatic infection
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The incidence of general complications was 11 (68.7%)
in group A versus 6 (40%) in group B (p=0.10), as presented
in Table 5. With regards to infectious complications, 11 (68.8%)
cases occurred in group A and 3 (20%) in group B (p=0.006). The
distribution of patients with acute pancreatitis in groups A and B
by type of complication are presented in Table 6.
The hospitalization time was 22.25±11.07 days in group
A and 25.47±5.55 days in group B (p=0.320). The majority of
patients were discharged (81.3%); although the incidence of death
was 18.75% in group A, whereas no patients died in group B
(p=0.226). No patients in either group required an interruption in
nutritional support administration because of feeding intolerance
or disease reactivation.
Discussion
In this study, patients were classified into two groups
according to type of nutritional support received, and results from
each group were compared. The study sample was from a single
service, and patients were cared for by the same team, following
the same diagnostic and therapeutic protocol throughout the
study period. There was no statistical difference between the
two groups based on demographic data, etiology, spectrum of
severity, duration of hospitalization, or clinical or surgical
treatment throughout the study period, and patients differed only
in the type of nutritional support used.
From 1995 to 1999, all patients were fed by the parenteral
route, constituting 51.6% of the total cases. From 2000 to 2003,
all patients were fed through the jejunal route (48.3%). These
findings are in conformity with the history of nutritional support.
Total parenteral nutrition was initially the accepted standard for
the preferred route in severe acute pancreatitis3. Nonetheless,
recent prospective and randomized studies have shown that
providing nutrients directly to the digestive tract is much more
advantageous than doing so by the parenteral route, principally
because the integrity of the intestinal mucosal barrier is maintained,
which is now known to be as important as allowing the pancreas to
rest12. The enteral nutritional support appears, therefore, to be an
advantageous alternative route for feeding patients with severe
acute pancreatitis8,13,14 and has been used more frequently in the
last five years13.
The majority of patients in both groups had severe
pancreatitis (Balthazar E), but there were more of these patients
in the enteral group, although this was not statistically significant
(p=0.21) and was probably due to small sample size. Disease
severity was defined by CT evaluation of the degree of pancreatic
and peripancreatic abnormalities. Balthazar et al.11 demonstrated
that only CT evaluation of pancreatic and peripancreatic
abnormalities was sensitive enough to predict clinical outcomes.
Currently, abdominal CT with intravenous contrast is the most
precise test for diagnosing and staging acute pancreatitis and
its complications11. Abdominal CT detects necrosis as a focal or
diffuse area of reduced contrast uptake due to pancreatic
parenchyma14 with a sensitivity of 87% and can detect necrosis
with a sensitivity >90%11.
Prophylaxis for pancreatic infection was used equally in
the two groups, with no statistically significant difference between
them (p=0.654). Imipenem was the drug of choice in both groups
(p=1.00), and was also used for a similar length of time (p=0.672).
The presence of abscesses or secondary infection of the pancreatic
parenchyma significantly affected both morbidity and mortality.
TABLE 5 - Distribution of patients with acute pancreatitis in groups A
and B by presence of general complications or infections
  A 
N (%) 
B 
  N (%) 
Complications 
Yes 11(68.8) 6(40.0) 
No 5(31.2) 9(60.0) 
Total 16(100.0) 15(100.0) 
 Chi-squared p=0.10
Infections 
Yes 11(68.8) 3(20.0) 
No 5(31.2) 12(80.0) 
Total 16(100) 15(100.0) 
 Chi-squared p=0.006
TABLE 6 - Distribution of patients with acute pancreatitis in groups A
and B by type of complication
Complication A % B % 
Catheter infection 4 25.4 2 13.4 
Pancreatic pseudocyst - - 3 20.0 
Septic necrosis + pancreatic 
abscess + catheter infection 
1 6.2 – – 
Septic necrosis + pancreatic 
abscess 
1 6.2 – – 
Septic necrosis + MOFS + 
catheter infection 
1 6.2 – – 
Septic necrosis + catheter 
infection 
1 6.2 - - 
Septic necrosis + pancreatic 
abscess+ MOFS 
1 6.2 - - 
Bacteremia 1 6.2 1 6.6 
MOFS + pneumonia  1 6.2 – – 
Without complication 5 31.2 9 60.0 
Total 16 100.0 15 100.0
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Bacterial infection of necrotic pancreatic tissue occurs in
approximately 40-70% of severe pancreatitis cases, and as the most
serious complication is responsible for more than 80% of mortality
in acute pancreatitis cases15. The microorganisms that cause
pancreatic infection and sepsis in these patients are usually
common Gram-negative enteric bacteria that have translocated
from the intestinal lumen as a result of the loss of mucosal barrier
integrity16. Clinical studies have confirmed that imipenem has
excellent penetration into pancreatic tissue and broad-spectrum
coverage of the bacteria that most commonly infect the pancreas.
Imipenem reduces the incidence of septic complications and should
therefore be used for patients with severe acute pancreatitis for a
period of two weeks17.
In general, complications were more common in the
parenteral group (68.7% versus 40.0%), without a statistically
significant difference (p=0.10); however, this may indicate a trend
towards worse results in the parenteral group.
A significantly greater prevalence of catheter, pancreatic
and peripancreatic tissue infections in the parenteral group was
observed (p=0.006). Other authors have also demonstrated that total
parenteral nutritional support was associated with many infectious
complications such as catheter sepsis3 and sepsis of intestinal
origin due to dysfunction of the intestinal mucosa barrier4.
Explanations for this observation include the fact that total
parenteral nutrition does not nourish the enterocyte; in addition,
nutrients are largely absent in the intestinal lumen, particularly
glutamine, which plays an important role in mucosal trophism18.
A previous prospective randomized study that evaluated
the impact of early total parenteral nutrition in acute pancreatitis
showed that the group that received early parenteral nutrition had
significantly longer hospitalizations and a greater incidence of
catheter sepsis, compared with a control group that received only
analgesia and fluid resuscitation19.
On the other hand, enteral nutritional support is safe in
patients with severe acute pancreatitis, as it is not implicated in
additional stimulation of pancreatic function, nor does it impose
the inconveniences of total parenteral nutrition6,9,10. Enteral
nutrition has been referred to as the most physiological type
of nutritional support and holds promise for improving outcomes
in surgical patients, particularly after severe trauma and acute
pancreatitis15,20.
A proposed mechanism for this clinical improvement
suggests that intestinal feeding maintains the integrity of the
intestinal mucosal barrier against translocation of bacteria and
toxins20. Moreover, in contrast to total parenteral nutrition, enteral
feeding appears to modulate the acute phase response and
maintain visceral protein metabolism, suggesting inhibition of the
splenic cytotoxic response21.
Several controlled studies that compared enteral with
parenteral nutrition in acute pancreatitis have shown that enteral
jejunal feeding is well tolerated and has clear advantages over
parenteral feeding, especially for reduction of septic complications,
a more rapid resolution of toxicity and stress caused by the
disease, greater ease of management, and cost reductions by 3–4
fold6,9. More recent studies have confirmed the advantages of
enteral nutrition over parenteral, with respect to tolerability, safety
and reduction of septic complications13.
Pancreatic surgery was performed only for complications
and only in the parenteral group, although this was not statistically
significant when compared with the enteral group (p= 0.226), due
perhaps to the small sample size. However, this could indicate a
trend towards greater morbidity in this patient group.
Biliary interventions were all done electively, and the
majority were in the enteral group. In this group, there were no
infectious complications in the pancreas, even though a greater
number of patients were Balthazar class E (71.4%). However, this
result was not statistically different (p=0.21). Indications for
mandatory surgery for acute pancreatitis were the presence of
complications such as septic necrosis or pancreatic abscess.
CT-guided percutaneous drainage failed in over 40% of cases;
therefore, open surgical drainage was frequently used as an initial
procedure22.
The length of hospitalization was similar in both groups,
with no statistical difference between them (p=0.320). This result
was also found in other studies6,12. With respect to disease
progression, death occurred only in the parenteral group, although
this was not statistically significant (p=0.226). Studies have shown
that the use of enteral feeding reduces length of hospital stay,
morbidity and mortality, compared to total parenteral nutrition13.
The results of this study confirmed previous reports in
the literature, especially those from recent years, i.e., that enteral
nutrition is perfectly viable and safe for treatment of severe acute
pancreatitis, free from additional pancreatic stimulation, and clearly
advantageous in all aspects when compared to parenteral nutrition.
However, a deficiency of this study is its retrospective nature and
relatively small sample size. Therefore, studies with larger sample
sizes should be done to better define the role of enteral nutritional
support in the treatment of severe acute pancreatitis.
This study demonstrated that enteral nutritional support
is safe and effective when compared to parenteral support. There
was no difference between the groups based on general
complications; however, the group that received enteral nutrition
presented with fewer septic complications. There was also no
difference between the groups based on mortality and length of
hospitalization.
Conclusion
Enteral nutritional support is associated with fewer septic
complications compared to parenteral nutritional support.
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